ArticleExperimental biology and medicine (Maywood, N.J.)2016

A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic options.

Hannah R Wardill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.